You are here: Industry Insights > AstraZeneca

News List

Imfinzi Approved in US for Less-Frequent, Fixed-Dose Use americanpharmaceuticalreview
December 08, 2020
AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the approved indications of unresectable Stage III non-small cell lung cancer (NSCLC) after chemoradiation therapy ..
AstraZeneca’s heart failure treatment Forxiga gets approval in Japan pharmaceutical-technology
December 02, 2020
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved AstraZeneca’s Forxiga (dapagliflozin) for treating patients with chronic heart failure (HF) who are receiving standard of care in the country.
AZ sells rights to statin med Crestor to Grünenthal pharmatimes
December 01, 2020
AstraZeneca (AZ) has announced that it will sell the rights to statin medication Crestor to Grünenthal in over 30 European countries.
Putting the vulnerable first could end the pandemic faster expresspharma
December 01, 2020
The role of serendipity in science came to the fore yet again when AstraZeneca and the University of Oxford revealed that a dosing error was at the heart of their COVID-19 vaccine candidate being tested as a half-dose followed by a full dose.
AstraZeneca likely to conduct new global low-dose Covid-19 vaccine trial pharmaceutical-technology
November 30, 2020
AstraZeneca may initiate an additional global trial to evaluate the efficacy of its Covid-19 vaccine candidate, AZD1222, using a lower dosage.
Britain presses on with AstraZeneca vaccine amid questions over trial data expresspharma
November 30, 2020
Britain gave AstraZeneca’s COVID-19 vaccine a vote of confidence on Friday when it asked its regulator to assess the shot for a rollout after experts raised questions about trial data and the company said it may run another study to gauge efficacy.
Serum Institute says in active talks with Indian government around potential COVID-19 vaccines expresspharma
November 30, 2020
Serum Institute of India (SII) is in active discussions with the Indian government on pricing and distribution of potential COVID-19 vaccines, said Adar Poonawalla, Chief Executive SII.
When and which COVID-19 vaccines are likely to be available in Asia expresspharma
November 27, 2020
Many Asian countries do not expect to receive big amounts initially, and below are estimated distribution timelines, supply deals announced so far and clinical trials under way in the region.
AstraZeneca signs MoU with RSSDI to empower one crore Indian Diabetic patients by 2023 expresspharma
November 27, 2020
This initiative will empower patients/caregivers to have conversations around Diabetes and make informed decisions about the management of the disease.
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine expresspharma
November 27, 2020
Instead of adding the trial to an ongoing US process, AstraZeneca might launch a fresh study to evaluate a lower dosage of its vaccine that performed better than a full dosage.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page